GeneDx Holdings Corp.
WGSDiagnostics & Research
$69.06−2.76%As of Oct 30vs prior close
- Market cap
- $2.1B
- P/E (TTM)
- –
- P/E (FY1)
- 525.5×
- From 52W high
- −58.77%
- EPS (LTM)
- -$3.62
- Revenue (LTM)
- $454.4M
- Net margin
- -23.40%
- Dividend yield
- 0.00%
Nomior Score
18
Speculative ChargeSpeculativeBottom 6% of the scored universe
Growth68
Quality27
Value24
Momentum17
Resilience26
Growth
+13.86%revenue a year over 6 fiscal years
YE19 $196.2MLTM $454.4M
Connections
Revenue to profitQ2 YE26
The operating loss was 15% of revenue, wider by 24 pts on a year.
Who owns it
2funds